Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1895 1
1944 1
1946 4
1947 7
1948 1
1949 1
1950 3
1951 1
1953 1
1956 1
1957 2
1958 2
1959 7
1960 10
1961 7
1962 10
1963 3
1964 8
1965 4
1966 3
1967 2
1971 2
1972 1
1974 3
1976 2
1977 3
1978 4
1979 3
1980 5
1981 3
1982 2
1983 6
1984 1
1985 1
1986 1
1987 2
1988 4
1989 2
1990 5
1991 7
1992 7
1993 5
1994 22
1995 13
1996 17
1997 17
1998 26
1999 23
2000 18
2001 16
2002 35
2003 28
2004 37
2005 42
2006 31
2007 48
2008 48
2009 59
2010 73
2011 73
2012 55
2013 61
2014 59
2015 71
2016 88
2017 91
2018 87
2019 118
2020 117
2021 151
2022 154
2023 138
2024 59

Text availability

Article attribute

Article type

Publication date

Search Results

1,789 results

Results by year

Filters applied: . Clear all
Page 1
Frailty in Critical Care Medicine: A Review.
De Biasio JC, Mittel AM, Mueller AL, Ferrante LE, Kim DH, Shaefi S. De Biasio JC, et al. Among authors: mueller al. Anesth Analg. 2020 Jun;130(6):1462-1473. doi: 10.1213/ANE.0000000000004665. Anesth Analg. 2020. PMID: 32384336 Free PMC article. Review.
Naringenin: A potential flavonoid phytochemical for cancer therapy.
Motallebi M, Bhia M, Rajani HF, Bhia I, Tabarraei H, Mohammadkhani N, Pereira-Silva M, Kasaii MS, Nouri-Majd S, Mueller AL, Veiga FJB, Paiva-Santos AC, Shakibaei M. Motallebi M, et al. Among authors: mueller al. Life Sci. 2022 Sep 15;305:120752. doi: 10.1016/j.lfs.2022.120752. Epub 2022 Jun 29. Life Sci. 2022. PMID: 35779626 Review.
Allergic Conjunctivitis: An Update.
Mueller A. Mueller A. Handb Exp Pharmacol. 2022;268:95-99. doi: 10.1007/164_2021_491. Handb Exp Pharmacol. 2022. PMID: 34136960
A Multi-Institutional Phase 2 Trial of Ablative 5-Fraction Stereotactic Magnetic Resonance-Guided On-Table Adaptive Radiation Therapy for Borderline Resectable and Locally Advanced Pancreatic Cancer.
Parikh PJ, Lee P, Low DA, Kim J, Mittauer KE, Bassetti MF, Glide-Hurst CK, Raldow AC, Yang Y, Portelance L, Padgett KR, Zaki B, Zhang R, Kim H, Henke LE, Price AT, Mancias JD, Williams CL, Ng J, Pennell R, Pfeffer MR, Levin D, Mueller AC, Mooney KE, Kelly P, Shah AP, Boldrini L, Placidi L, Fuss M, Chuong MD. Parikh PJ, et al. Among authors: mueller ac. Int J Radiat Oncol Biol Phys. 2023 Nov 15;117(4):799-808. doi: 10.1016/j.ijrobp.2023.05.023. Epub 2023 May 19. Int J Radiat Oncol Biol Phys. 2023. PMID: 37210048 Free article. Clinical Trial.
Inhibition of LILRB2 by a Novel Blocking Antibody Designed to Reprogram Immunosuppressive Macrophages to Drive T-Cell Activation in Tumors.
Umiker B, Hashambhoy-Ramsay Y, Smith J, Rahman T, Mueller A, Davidson R, Meyer C, Patankar G, Alam MM, Jaffe S, Krukenberg K, Goodman A, Spaulding V, Priess M, Dhaneshwar A, Wong M, Diiorio A, O'Malley K, McGrath L, Willer M, Pepper L, Gostissa M, Kis-Toth K, Wiederschain D, Cohen H, Shaffer DR. Umiker B, et al. Among authors: mueller a. Mol Cancer Ther. 2023 Apr 3;22(4):471-484. doi: 10.1158/1535-7163.MCT-22-0351. Mol Cancer Ther. 2023. PMID: 36780212
1,789 results